Ophthalmic medication

Details Ophthalmic medication Ophthalmic medication

A - Human Necessities

61

K

167/182, 167/187

A61K 31/65 (2006.01) A61K 9/00 (2006.01) A61K 31/425 (2006.01) A61L 12/14 (2006.01) A61L 26/00 (2006.01)

Patent

CA 2032366

ABSTRACT OF THE DISCLOSURE Glycosaminoglycan polysulfates (GAGPS) have been found to be useful in ophthalmic medications in the prevention and treatment of eye injuries. Particularly useful are GAGPS having a molecular weight in the range 5,000-20,000 daltons. GAGPS-containing ophthalmic medications are usefully combined with an antibiotic in the treatment of ocular fungal or bacterial infections or with an antibiotic in the treatment of fungal or bacteria infections or with an anti- glaucoma agent, such as pilocarpine or epinephrine, in the treatment of glaucoma. Also, of particular usefulness are GAGPS solutions or dispersions used to enhance healing after corneal abrasion or surgical insult.

Affiliated with

Also associated with

Rating

Ophthalmic medication does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic medication, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic medication will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1935656